If activity levels are low, the body does not need to use large amounts of fat as fuel
Food and Drug Administration GLD: Glucose-lowering drug GLP-1 RA: Glucagon-like peptide-1 receptor agonist Hb1Ac: Haemoglobin A1c HF: Heart failure HFpEF: Heart failure with preserved ejection fraction HFrEF: Heart failure with reduced ejection fraction HHF: Hospitalisation for heart failure HR: Hazard ratio KDIGO: Kidney Disease Improving Global Outcomes MACE: Major adverse cardiovascular events MI: Myocardial infarction NR: Not reported RRR: Relative risk reduction SCr: Serum creatinine SGLT2: Sodiumglucose transporter 2 T2D: Type 2 diabetes TIMI: Thrombolysis In Myocardial Infarction 3P-MACE: 3-Point major adverse cardiovascular events 4P-MACE: 4-Point major adverse cardiovascular events References Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al
Nauck MA, Homberger E, Siegel EG, Allen RC, Eaton RP, Ebert R, Creutzfeldt W
Improperly synthesized or degraded GHK-CU may contain free copper ions that cause oxidative damage without providing peptide benefits
Popular Stories Upcoming Events